BackGlaxoSmithKline Pharmaceuticals Limited Overview

GlaxoSmithKline Pharmaceuticals Limited Inventory

GlaxoSmithKline Pharmaceuticals Limited's inventory is $0.

Get informed when a big investor buys or sells

+ Follow
Inventory
$0.00

Peer trimmed avg / median

Loading

GlaxoSmithKline Pharmaceuticals Limited Inventory History

Loading

GlaxoSmithKline Pharmaceuticals Limited vs. peers: Inventory Comparison

Loading

GlaxoSmithKline Pharmaceuticals Limited Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) FAQ

GlaxoSmithKline Pharmaceuticals Limited posts a inventory of $0 as of June 2026. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, GlaxoSmithKline Pharmaceuticals Limited's inventory was $0. The latest reading is $0 (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Inventory is one piece of GlaxoSmithKline Pharmaceuticals Limited's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for GLAXO.NS's inventory usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; GlaxoSmithKline Pharmaceuticals Limited's other metric pages and overview cover the third.